In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate.
Release date: August 15, 2017; Expiration date: August 15, 2018
Upon completion of this activity, participants will be able to:
• Identify the life cycle of Mansonella perstans.
• Distinguish the most common country of origin among patients infected with Mansonella perstans in the current study.
• Assess common symptoms of infection with Mansonella perstans.
• Identify first-line treatment for Mansonella perstans in the current study.
Thomas J. Gryczan, MS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Thomas J. Gryczan, MS, has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor, UC Irvine Department of Family Medicine; Associate Dean for Diversity and Inclusion, UC Irvine School of Medicine, Irvine, California, USA. Disclosure: Charles P. Vega, MD, has disclosed the following financial relationships: served as an advisor or consultant for McNeil Consumer Healthcare; served as a speaker or a member of a speakers bureau for Shire Pharmaceuticals.
Disclosures: Federico Gobbi, PhD, MD, DTM&H; Anna Beltrame, MD, PhD; Dora Buonfrate, MD, DTM&H; Silvia Staffolani, MD; Monica Degani; Maria Gobbo; Andrea Angheben, MD; Stefania Marocco, MD; and Zeno Bisoffi, MD, PhD, DTM&H, have disclosed no relevant financial relationships.
To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 75% passing score) and earn continuing medical education (CME) credit, please go to http://www.medscape.org/journal/eid. Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers.
Only one answer is correct for each question. Once you successfully answer all post-test questions, you will be able to view and/or print your certificate. For questions regarding this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact CME@medscape.net. American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please go to https://www.ama-assn.org. The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRACategory 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the AMA PRA CME credit certificate, and present it to your national medical association for review.
Imported Infections with Mansonella perstans Nematodes, Italy
1. You are seeing a 30-year-old man who recently emigrated from sub-Saharan Africa. His sister, who emigrated from their home country years ago, brings him in "to get checked out for any illnesses or parasites." You consider whether the patient might have infection with Mansonella perstans. Which one of the following statements regarding the life cycle of M. perstans is most accurate?
A. It is transmitted to humans via mosquitoes
B. Macrofilariae live in serous body cavities
C. Macrofilariae are the final infection stage of M. perstans
D. Microfilariae are released into the bloodstream approximately 1 month after the initial infection
2. Which one of the following countries was associated with the highest number of infections with M. perstans in the current study?
B. Democratic Republic of the Congo
3. You perform a review of systems for infection. Which one of the following symptoms was most common among individuals with M. perstans in the current study?
D. Abdominal pain
4. The patient's symptoms and serologic testing suggest infection with M. perstans. According to the results of the current study, what has been first-line treatment for M. perstans since 2009?
A. Levamisole, followed by mebendazole
B. Mebendazole alone
C. Albendazole, followed by ivermectin
D. Mebendazole, followed by doxycycline
1. The activity supported the learning objectives.
2. The material was organized clearly for learning to occur.
3. The content learned from this activity will impact my practice.
4. The activity was presented objectively and free of commercial bias.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Exit Notification / Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Gobbi F, Beltrame A, Buonfrate D, Staffolani S, Degani M, Gobbo M, et al. Imported Infections with Mansonella perstans Nematodes, Italy. Emerg Infect Dis. 2017;23(9):1539-1542. https://doi.org/10.3201/eid2309.170263
Gobbi F, Beltrame A, Buonfrate D, et al. Imported Infections with Mansonella perstans Nematodes, Italy. Emerging Infectious Diseases. 2017;23(9):1539-1542. doi:10.3201/eid2309.170263.
Gobbi, F., Beltrame, A., Buonfrate, D., Staffolani, S., Degani, M., Gobbo, M....Bisoffi, Z. (2017). Imported Infections with Mansonella perstans Nematodes, Italy. Emerging Infectious Diseases, 23(9), 1539-1542. https://doi.org/10.3201/eid2309.170263.
Imported Infections with Mansonella perstans Nematodes, Italy
Volume 23, Number 9—September 2017
Article Views: 364
Data is collected weekly and does not include downloads and attachments. View data is from .
Click a source for Altmetric details
What is the Altmetric Attention Score?
The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received. The score is derived from an automated algorithm, and represents a weighted count of the amount of attention Altmetric picked up for a research output.